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Key points
 Low intrinsic aerobic capacity is associated with increased all-cause and liver-related mortality
in humans.
 Low intrinsic aerobic capacity in the low capacity runner (LCR) rat increases susceptibility to
acute and chronic high-fat/high-sucrose diet-induced steatosis, without observed increases in
liver inflammation.
 Addition of excess cholesterol to a high-fat/high-sucrose diet produced greater steatosis in LCR
andhigh capacity runner (HCR) rats.However, the LCR rat demonstrated greater susceptibility
to increased liver inflammatory and apoptotic markers compared to the HCR rat.
 The progressive non-alcoholic fatty liver disease observed in the LCR rats following western
diet feeding was associated with further declines in liver fatty acid oxidation andmitochondrial
respiratory capacity compared to HCR rats.
Abstract Low aerobic capacity increases risk for non-alcoholic fatty liver disease and liver-related
diseasemortality, butmechanismsmediating these effects remain unknown.We recently reported
that rats bred for low aerobic capacity (low capacity runner; LCR) displayed susceptibility to high
fat diet-induced steatosis in association with reduced hepatic mitochondrial fatty acid oxidation
(FAO) and respiratory capacity compared to high aerobic capacity (high capacity runner; HCR)
rats. Here we tested the impact of aerobic capacity on susceptibility for progressive liver disease
following a 16-week ‘western diet’ (WD) high in fat (45% kcal), cholesterol (1% w/w) and
sucrose (15% kcal). Unlike previously with a diet high in fat and sucrose alone, the inclusion
of cholesterol in the WD induced hepatomegaly and steatosis in both HCR and LCR rats, while
producing greater cholesterol ester accumulation in LCR compared to HCR rats. Importantly,
WD-fed low-fitness LCR rats displayed greater inflammatory cell infiltration, serum alanine
transaminase, expression of hepatic inflammatory markers (F4/80, MCP-1, TLR4, TLR2 and
IL-1β) and effector caspase (caspase 3 and 7) activation compared to HCR rats. Further, LCR
rats had greaterWD-induced decreases in complete FAO andmitochondrial respiratory capacity.
Intrinsic aerobic capacity had no impact on WD-induced hepatic steatosis; however, rats bred
for low aerobic capacity developed greater hepatic inflammation, which was associated with
reduced hepatic mitochondrial FAO and respiratory capacity and increased accumulation of
cholesterol esters. These results confirm epidemiological reports that aerobic capacity impacts
progression of liver disease and suggest that these effects are mediated through alterations in
hepatic mitochondrial function.
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Introduction
Aerobic capacity, also termed cardiorespiratory fitness,
is the most powerful predictor of cardiovascular and
all-cause mortality independent of other major risk
factors (Myers et al. 2002). Low aerobic capacity is
also an independent predictor for multiple metabolic
disease states including non-alcoholic fatty liver disease
(NAFLD; Church et al. 2006). Aerobic capacity is sub-
stantially reduced in NAFLD patients (Croci et al.
2012), and low initial aerobic capacity negatively impacts
lifestyle-induced treatment of NAFLD (Kantartzis et al.
2009), increasesmortality in chronic liver disease patients,
and reduces survivability following liver transplant
(Bernal et al. 2014). However, potential mechanisms by
which aerobic capacity mediates susceptibility to NAFLD
and liver disease are not well understood.
High calorie, high fat diets (HFD) are associated with
NAFLD risk and obesity in humans and are commonly
utilized to induce hepatic steatosis in rodent models.
However, chronic HFD-induced hepatic steatosis does
not progress to non-alcoholic steatohepatitis (NASH)
in rodent models (Matteoni et al. 1999), whereas we
and others have shown that the addition of refined
sugar and/or cholesterol to an HFD induces NASH-like
outcomes (Gan et al. 2014; Bashiri et al. 2016; Linden et al.
2016). Inappropriate cholesterol metabolism has received
considerable attention in human and animal studies of
NAFLD, and has been observed to modulate multiple
pathways triggering NASH development (Min et al. 2012;
Arguello et al. 2015). In support of these findings,
large epidemiological reports link elevated cholesterol
consumption with increased risk of NASH (Musso et al.
2003). Therefore, both intrinsic aerobic capacity and
western diet (WD; high in fat, sugar and cholesterol)
clearly impact prevalence and progression of NAFLD
severity including the transition to NASH, but the inter-
action of these factors has never been examined.
In order to assess the role of intrinsic aerobic capacity
in modulating the susceptibility to WD-induced NASH,
we utilized the high capacity runner (HCR)/low capacity
runner (LCR) rat model system created by selective
breeding for divergent intrinsic aerobic capacities (Koch&
Britton, 2001; Ren et al. 2013). We have previously shown
that low intrinsic aerobic capacity increases susceptibility
for hepatic steatosis under chow and acute and chronic
HFD conditions (increased lipids and sucrose), effects
we have attributed to robust reductions in hepatic
mitochondrial content,mitochondrial fatty acid oxidation
(FAO) and mitochondrial respiratory capacity (MRC) in
LCR vs. HCR rats (Thyfault et al. 2009; Morris et al. 2014,
2016). The robust differences in hepatic mitochondrial
oxidative capacity play a role in the larger whole body
differences in energy metabolism in the HCR/LCR rats
that has been described by Britton, Koch and colleagues as
the ‘energy transfer hypothesis’. The hypothesis contends
that high vs. low aerobic capacity leads to a greater rate
of thermogenesis or metabolic entropy, and is supported
by evidence that HCR rats have higher body and skeletal
muscle temperature, higher resting energy expenditure,
and greater mitochondrial metabolism in skeletal muscle
and adipose. Here we tested the hypothesis that reduced
intrinsic aerobic capacity and associated reductions in
hepatic mitochondrial content, FAO and MRC would
result in increased susceptibility for NASH in the LCR rats
while the high-fitness HCR rats that display elevations in
these hepatic mitochondrial features would be protected.
Methods
Animals
HCR/LCR rat development and characterizationwere pre-
viously described (Koch & Britton, 2001; Wisloff et al.
2005; Noland et al. 2007; Thyfault et al. 2009; Novak et al.
2010; Gavini et al. 2014; Morris et al. 2014; Vieira-Potter
et al. 2015). Male rats (Generation 35) 25–30 weeks of age
were singly housed (25°C, 12-hour light cycle) with ad
lib access to water, and acclimatized to the low-fat, control
diet (LFD) (D12110704; 10% kcal fat, 3.5% kcal sucrose,
3.85 kcal g−1; Research Diets, Inc., New Brunswick, NJ,
USA) for 2 weeks prior to the initiation of the western
diet (WD) (D09071604; 45% kcal fat, 17% kcal sucrose,
1% cholesterol w/w, 4.68 kcal g−1; Research Diets, Inc.).
Food intake and body weight were monitored weekly
during a 16-week dietary intervention (n = 8 in each
group). Animals were anaesthetized with pentobarbital
(75 mg kg−1, I.P.) prior to killing by exsanguination
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and bilateral thoracotomy. Tissues were collected and
snap frozen in liquid nitrogen after an overnight fast.
The animal protocols were approved by the Institutional
Animal Care and Use Committee at the University of
Missouri and the Subcommittee for Animal Safety at the
Harry S. Truman Memorial VA Hospital.
Body composition analysis
Body composition was measured by magnetic resonance
using the EchoMRI-900 analyser (EchoMRI, Houston,
TX, USA). Body composition was determined before the
initiation ofWD and periodically throughout the 16-week
dietary intervention.
Liver lipid analysis
Liver triacylglycerol concentration was determined as
previously described using a commercially available kit
(F6428, Sigma-Aldrich, St Louis, MO, USA) (Thyfault
et al. 2009). Liver cholesterol was determined utilizing a
commercially available kit (ab65359, Abcam, Cambridge,
MA, USA).
Liver histochemical staining
Haematoxylin and eosin (H&E) staining was performed
as described previously (Rector et al. 2010).
Mitochondrial isolation
Mitochondria were isolated from rat liver tissue, as pre-
viously described (Morris et al. 2012). Briefly, tissue was
homogenized (Teflon on glass) in cold livermitochondrial
isolation buffer (220 mannitol, 70 sucrose, 10 mM Tris,
and 1 mM EDTA, adjusted to pH 7.4 with KOH)
and centrifuged (1500 g, 10 min, 4°C). The super-
natant was serially centrifuged (8000 g–6000 g–4000 g,
10 min, 4°C), with the pellet resuspended (glass on glass)
in liver mitochondrial isolation buffer following each
centrifugation. Theprotein concentrationwas determined
by bicinchoninic acid assay.
Mitochondrial respiration
Mitochondrial oxygen consumption was measured using
a Clark-type electrode system (Strathkelvin Instruments,
North Lanarkshire, UK) as previously described (Morris
et al. 2013). The consumption of oxygen in nmol min−1
was normalized to mitochondrial protein in the
respirometer cell.
Palmitate oxidation by liver homogenate
The oxidation of [1-14C]palmitate was measured in
fresh liver homogenates as previously described (Morris
et al. 2012). Fatty acid oxidation was assessed by
measuring the production of 14CO2 (complete FAO)
and 14C-acid-soluble metabolites in a sealed trapping
device at 37°C containing palmitate (200 μM). In
order to approximate the carnitine palmitoyltransferase I
(CPT-1)-mediated and non-CPT-1-mediated FAO in the
liver homogenate, parallel incubations were included with
the CPT-I inhibitor etomoxir (100 μM). One animal for
each group was analysed daily. Values were normalized to
the wet weight of the liver tissue sample.
Pyruvate oxidation by isolated mitochondria
The oxidation of 5 mM pyruvate ([2-14C]pyruvate)
to 14CO2 by isolated liver mitochondria was used
to monitor pyruvate oxidation and approximate
tricarboxylic acid (TCA) cycle flux as previously described
(Morris et al. 2012).
Acyl-carnitine analysis
Plasma and liver acyl-carnitines were measured by
liquid chromatography–tandem mass spectrometry
(LC-MS/MS) on an API 3200 triple quadrupole mass
spectrometer (Applied Biosystems/Sciex Instruments,
Foster City, CA, USA) as previously described (Satapati
et al. 2012). Briefly, liver and plasma free carnitine and
acyl-carnitines were extracted, derivatized, and individual
acyl-carnitine peaks were then quantified by comparison
with a 13C internal standard (Cambridge Isotopes,
Andover, MA, USA). Liver metabolites were normalized
to tissue sample weight.
Citrate synthase activity
Citrate was determined as previously described (Srere,
1969). Values were normalized to the wet weight of the
liver tissue sample.
Liver nucleotides
Liver ATP, ADP and AMP were measured by mass
spectrometry as described previously (Satapati et al.
2015). Briefly, frozen liver samples were spiked
with [13C10,15N5]ATP and [13C10,15N5]AMP (Sigma-
Aldrich) internal standards before extraction. Analysis
was performed on an API 3200 triple quadrupole
mass spectrometer in positive electrospray ionization
mode. A reverse-phase C18 column (Waters xBridge,
150 × 2.1 mm, 3 μm) and a gradient elution consisting
of water/methanol (5:95, v/v) with 4 mM dibutylamine
acetate (eluentA) andacetonitrilewith4mMdibutylamine
acetate (eluent B) was used to achieve separation.
Nucleotides were quantified in standard solutions and
samples by positive-ion-mode electrospray ionization and
C© 2017 The Authors. The Journal of Physiology C© 2017 The Physiological Society
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Table 1. SYBR RT-PCR primers used in the study
Gene Forward primer Reverse primer
CycB (PPIB) CTTAGCTACAGGAGAGAAAGG TTCAGCTTGAAGTTCTCCATC
F4/80 (EMR1) GGAGGACCAATGTTCCAGGG TGGGCAAGAACAGCTGTAGG
MCP-1 (CCL2) GAAGCTGTAGTATTTGTCACC TTCTAATGTACTTCTGGACCC
IL1B TAAGCCAACAAGTGGTATTC AGGTATAGATTCTTCCCCTTG
TLR2 AAAAACTGCTGAGATTTTGC TACTAACATCCAACACCTCC
TLR4 ACCTAGATCTGAGCTTCAAC TTGTCTCAATTTCACACCTG
TLR9 AACCTCAGCCATAACATCC ACTTCCAGCAGTAAGTCTAC
CPT1a CCTACCACGGCTGGATGTTT TACAACATGGGCTTCCGACC
HADHA ACAGGTTTACAAAACAGTGG CTCTCCAAATTTCTCTGATTCG
HMGCR GCCTCCATTGACATCCGGAGG AGGGATGGGAGGCCACAAAG
SOAT1 CTCATATGTCAGAGAGAATGTG AACTGCATAGCAACATAACC
SOAT2 GGTCAGATTCCTGATGAAAAG CCACATAATTCCACCTGATG
CES1d GAGATCCTGACTGAGAAGAG CTCAGAGATTTTCAGTGTTGG
CES1e TTCTGCCAACAATGATGAAC GTTGGTCTTTATTTCTGTCTGG
nCEH1 TGGCCACTGCAAAAAATCAGC AGGAAGTATTTGGTGGCCCA
CYP7a1 GCGAAGGCATTTGGACACAG ACCCAGGCATTGCTCTTTGA
CYP17a1 GGCGACAGAAATCTGGTGGA TGTCCATCAGGCTGGAGATA
HSD17b AAGAGCTTGCCAAATGGGGA TCTCTCTCATGACCGGGA
SRD5a1 GTGGTTAGTGGGCATGGTGA ATTCAAACAGGCCTCCCCTG
ABCG5 CCCTTTGATTTCTACATGGAC GTTCTTTCAATGTTCTCCAGG
ABCG8 AACAACCTGTGGATAGTACC GATGGCATAAAGAGGATGTG
ABCA1 GGGAGAGAATGCTGAATATC CATCTGAAAAACAGGTTTGG
SR-B1 (SCARB1) CATTCCTTGTTCCTAGACATC GACGGATTTGATGTACAGAC
LDLR CAGTGTGAAGATATTGACGAG TCATCTTACGTACCTCATGG
BSEP (ABCB11) TGGGGCTCGTCAGATAAGGA ACATGCGCTGGAGGAAATGA
NTCP (SCL10A1) CATTCAACTCTGTTCTACCATC TTTTGTTTGGTCCTTTGC
TGFb GGAAATCAATGGGATCAGTC CTGAAGCAGTAGTTGGTATC
COL1a TGGATTCCAGTTCGAGTATG AGTGATAGGTGATGTTCTGG
TNFa CTCACACTCAGATCATCTTC GAGAACCTGGGAGTAGATAAG
CD11c CAAAGCTGAGCTGGGAGACA TGGCTGCTGATGACAGTGTA
CD163 TGTAGTTCATCATCTTCGGTCC CACCTACCAAGCGGAGTTGAC
CD68 TCACAAAAAGGCTGCCACTCTT TCGTAGGGCTTCGTTGCTGTGCTT
CD64 GGACAGTGGCGAATACAGGT CTTCTGTGAGGACTCTGCGG
DR5 (TNFRSF10B) CATTAGGAAGGAAGTTGCTG CATTTGGTACAAGACCTCAC
Fas ATTATAAGCTCCTTTGGCTG CATCTGAGACATTCATTGGC
TNFRSF1a CTCCATACATTTGTAGGGATTC GGAGTTAGGGGCTTAGTAAC
NLRP3 AAGAGGAGTGGATAGGTTTA CTGTCTTTGATGGAGTAGAAC
multiple reaction monitoring. Liver nucleotides were
normalized to tissue sample weight. Liver energy charge
was calculated as ([ATP] + ½[ADP])/([ATP] + [ADP] +
[AMP]).
Western blotting
Triton X-100 cell lysates were used to produce Western
blot-ready Laemmli samples. Samples were separated
by SDS-PAGE, transferred to polyvinylidene difluoride
membrane and probed with primary antibodies. Bcl-2,
Bcl-xL, Bax, Bak, caspase 3 and caspase 7 antibodies were
purchased from Cell Signaling Technology (Danvers, MA,
USA). HADHA antibody was purchased from Abcam.
CPT-1a antibody was purchased from Proteintech Group,
Inc. (Rosemont, IL, USA). Individual protein bands were
quantified using a densitometer (Bio-Rad Laboratories,
Hercules, CA, USA) and protein loading was corrected by
0.1% amido-black (Sigma-Aldrich) staining to determine
total protein as previously described (Morris et al. 2012).
mRNA expression
RNA and cDNA were prepared as previously described
(Morris et al. 2013). Real time quantitative PCR analysis
was performed utilizing a Prism 7000 (ThermoFisher
Scientific, Waltham, MA, USA) and SYBR green rat
primers (SigmaAldrich, St. Louis,MO,USA) (Table 1). All
gene specific valueswere normalized to relative cyclophilin
B mRNA expression values.
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Table 2. Animal characteristics following 16 weeks’ of low-fat diet (LFD) or western diet (WD) for high capacity runner (HCR) and
low capacity runner (LCR) rats
HCR LCR
LFD WD LFD WD
Anthropometrics
Final body weight (g) 436.9 ± 23.6 460.5 ± 19.2 511.6 ± 29.5∗ 560.8 ± 32.8∗
Weight gain (g) 50.8 ± 6.9 82.7 ± 9.7† 34.1 ± 7.1 88.9 ± 14.2†
Body fat % 19.3 ± 1.5 21.6 ± 1.5 24.6 ± 1.7∗ 26.8 ± 1.5∗
Change in body fat % 5.5 ± 1.2 6.3 ± 0.8 6.9 ± 0.9 10.2 ± 0.4∗∗ ,††
Energy intake (weekly average, kcal)a 387.8 ± 15.5 431.5 ± 10.6†† 394.7 ± 22.3 424.9 ± 18.9
Feed efficiency (weekly average, mg kcal−1)b 9.3 ± 1.4 11.4 ± 1.4 6.4 ± 1.5 11.9 ± 1.4††
Liver weight (g) 9.2 ± 0.5 18.2 ± 1.2† 9.9 ± 0.6 17.6 ± 1.4†
Serum
ALT (U l−1) 45.4 ± 4.2 126.1 ± 25.6† 51.6 ± 9.9 206.1 ± 30.6† ,∗∗
AST (U l−1) 99.8 ± 10.2 196.6 ± 38.1† 96.3 ± 11.5 238.9 ± 29.0†
ALP (U l−1) 118.0 ± 6.4 133.4 ± 10.2 71.0 ± 4.5∗∗ 118.3 ± 6.1††
Cholesterol (mg dl−1) 86.1 ± 6.4 92.1 ± 16.7 98.1 ± 7.9 134.0 ± 8.6∗∗ ,††
Plasma
Glucose (mg dl−1) 169.1 ± 8.5 174.5 ± 7.4 172.5 ± 9.9 167.9 ± 5.1
Insulin (ng ml−1) 1.39 ± 0.18 1.47 ± 0.19 1.08 ± 0.17 1.37 ± 0.21
Data are means ± SEM (n = 8). aAverage weekly energy intake during the 16 weeks’ diet. bWeekly feed efficiency as weekly body
weight gain divided by weekly energy intake. ∗P < 0.05 main effect HCR vs. LCR; †P < 0.05 main effect LFD vs. WD; ∗∗P < 0.05
HCR vs. LCR within diet; ††P < 0.05 LFD vs. WD within strain. ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate
aminotransferase.
Statistical analysis
Animals within strain were randomized by weight into the
two dietary groups. The main effects of phenotype and
diet were tested by using 2-way ANOVA (SPSS Statistics,
IBM, Armonk, NY, USA). Where significant main effects
were observed, post hoc analysis was performed using
least significant difference to test for any specific pairwise
differences. Statistical significance was set at P < 0.05.
Results
Animal characteristics
Final body weight was 16% less in HCR compared to
LCR rats regardless of diet (Table 2, P < 0.05). However,
16 weeks of WD produced significant weight gain in both
HCR and LCR rats compared to LFD (60% in each
strain, P < 0.05). The LCR rats displayed 20% higher
body fat percent than HCR rats across all diets (P< 0.05).
Interestingly, WD caused no change in body fat percent
in the HCR rats, but caused a 50% increase in the LCR
rats (P < 0.05). WD significantly increased liver weight
in both HCR and LCR rats compared to LFD (2 fold in
each strain, P < 0.05).
Fasting serum and plasma
Circulating glucose and insulin (Table 2)werenotdifferent
among groups. WD resulted in a significant > 2-fold
increase in aspartate aminotransferase (AST) in both
strains and a 2-fold and 4-fold increase in alanine
transaminase (ALT) in HCR and LCR rats, respectively
(P < 0.05), representing a 60% greater ALT in LCR
compared to HCR rats (P < 0.05). Alkaline phosphatase
(ALP) levels were40% lower in LCR compared to HCR
rats on LFD (P < 0.05), and only LCR rats displayed an
increase following WD (67%, P < 0.05). Finally, the WD
diet increased serum cholesterol levels only in the LCR rats
(37%, P < 0.05). In summary, reduced intrinsic aerobic
capacity results in WD-induced increases in body fat and
serum markers of liver damage.
Liver histology and lipid analysis
Liver H&E images show increased steatosis in both
strains following chronic WD (Fig. 1A); however, the
LCR rats displayed greater increases in inflammatory cell
infiltration than the HCR rats following WD feeding.
While differences in fibrosis markers, namely trans-
forming growth factor β (TGFb) and collagen, type I,
α 1 (Col1a1) mRNA expression, were observed due to
the WD in both strains (data not shown), no difference
was observed in picosirius red staining for fibrosis due
to either strain or diet. Unlike previous observations
(Thyfault et al. 2009; Morris et al. 2014, 2016), liver
triacylglycerol (TAG) content was found to be higher in
HCR compared to LCR rats on LFD (Fig. 1B, 35%,
P < 0.05). Chronic WD resulted in a > 3.5-fold increase
C© 2017 The Authors. The Journal of Physiology C© 2017 The Physiological Society
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Figure 1. High intrinsic aerobic capacity protects against high-fat/high-cholesterol diet-induced hepatic
steatosis and non-parenchymal cellular infiltration
A, representative H&E images. Scale bars represent 50 μm. B, liver triacylglycerol, total cholesterol, free cholesterol
and cholesterol ester determined biochemically. Values are means ± SEM (n = 8). §P < 0.05 interaction; ∗P < 0.05
main effect HCR vs. LCR; †P < 0.05 main effect LFD vs. WD, ∗∗P < 0.05 HCR vs. LCR within diet.
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Table 3. mRNA expression of genes for liver cholesterol metabolism, bile acid metabolism, transporters and inflammation
HCR LCR
Gene LFD WD LFD WD Interaction
Cholesterol ester metabolism
HMGCR 1.01 ± 0.06 0.60 ± 0.06†† 0.47 ± 0.04∗ 0.43 ± 0.05∗ P < 0.002
SOAT1 1.03 ± 0.11 3.25 ± 0.71† 0.94 ± 0.08 2.69 ± 0.45† NS
SOAT2 1.01 ± 0.04 0.62 ± 0.04†† 0.87 ± 0.07∗ 0.89 ± 0.03∗ P < 0.001
nCEH1 1.01 ± 0.06 1.19 ± 0.11 1.82 ± 0.21∗ 1.80 ± 0.18∗ NS
CES1d 1.07 ± 0.14 1.33 ± 0.29 0.93 ± 0.10 1.04 ± 0.17 NS
CES1e 1.00 ± 0.04 0.96 ± 0.11 1.23 ± 0.08∗ 1.12 ± 0.12∗ NS
Bile acid/steroidogenesis
CYP7a1 1.10 ± 0.17 1.44 ± 0.15 0.44 ± 0.07∗ 3.80 ± 0.64∗ ,†† P < 0.0001
CYP17a1 1.08 ± 0.26 0.41 ± 0.08†† 0.98 ± 0.21 0.85 ± 0.25 NS
HSD17b 0.93 ± 0.13 0.58 ± 0.09†† 1.51 ± 0.26∗ 2.65 ± 0.47∗ ,†† P < 0.02
SRD5a1 1.05 ± 0.13 0.30 ± 0.03 0.83 ± 0.8 0.31 ± 0.11 NS
Cholesterol/bile transporters
ABCG5 1.08 ± 0.16 1.86 ± 0.35†† 0.74 ± 0.14 0.92 ± 0.17∗∗ NS
ABCG8 1.07 ± 0.16 0.60 ± 0.17† 2.65 ± 0.53∗ 1.26 ± 0.23∗ ,† NS
ABCA1 1.02 ± 0.08 1.18 ± 0.06 1.00 ± 0.11 1.64 ± 0.15∗∗ ,†† P < 0.05
SR-B1 (SCARB1) 1.03 ± 0.09 0.80 ± 0.05†† 1.06 ± 0.07 1.04 ± 0.08∗∗ NS
LDLR 1.03 ± 0.09 0.35 ± 0.06† 0.91 ± 0.06 0.41 ± 0.02† NS
BSEP (ABCB11) 1.01 ± 0.05 0.88 ± 0.07† 1.33 ± 0.05∗ 1.03 ± 0.10∗ ,† NS
NTCP (SCL10A1) 1.01 ± 0.05 0.52 ± 0.06† 1.03 ± 0.10 0.70 ± 0.07† NS
Inflammation
NLRP3 1.09 ± 0.18 2.38 ± 0.41† 0.87 ± 0.08 2.81 ± 0.33† NS
TNFa 0.94 ± 0.11 3.39 ± 0.60† 0.69 ± 0.08 5.26 ± 1.33† NS
CD11c 1.00 ± 0.06 3.27 ± 0.46† 0.78 ± 0.12 4.04 ± 0.67† NS
CD68 1.08 ± 0.15 2.38 ± 0.40† 0.81 ± 0.06 2.56 ± 0.36† NS
CD64 0.94 ± 0.11 1.59 ± 0.20† 0.83 ± 0.07 1.89 ± 0.25† NS
Gene expression in liver was determined by RT-PCR. Relative expression of listed genes related to liver bile acid metabolism and
inflammation state were normalized to cyclophilin B (PPIB) and presented as means ± SEM (n = 7–8). ∗P < 0.05 main effect HCR vs.
LCR; †P < 0.05 main effect LFD vs. WD; ∗∗P < 0.05 HCR vs. LCR within diet; ††P < 0.05 LFD vs. WD within strain.
in liver TAG and increases in liver weight in both strains
(P < 0.05). The HCR rats maintained 38% greater liver
TAGs compared to LCR rats after the WD diet (P< 0.05).
Total liver cholesterol was increased 3-fold in both
strains following WD (Fig. 1B, P < 0.05), and hepatic
free cholesterol was increased 67% in HCR and 45% in
LCR rats (P < 0.05). Hepatic cholesterol esters robustly
increased in both groups following WD (16- and 29-fold,
respectively, P < 0.05), but were 32% higher in LCR than
HCR rats after WD (interaction, P < 0.05).
We next examined expression of several genes (i.e.
those for cholesterol metabolism, bile acid synthesis/
steroidogenesis, and cholesterol/bile acid transporters)
that may be responsible for strain or diet differences
in liver cholesterol ester levels (Table 3). Several genes
(e.g. HMGCR, SOAT2, CYP7a1, HSD17b and ABCA1)
displayed significant changes in expression between the
LCR and HCR rats following chronic WD (significant
interactions, P < 0.05), implicating intrinsic aerobic
capacity as a modulator of liver sterol homeostasis. These
data show that while HCR and LCR rats both display
WD-induced steatosis, the LCR rats with reduced intrinsic
aerobic capacity are much more susceptible to hepatic
cholesterol ester storage and inflammatory cell infiltration.
Liver inflammation
We next examined hepatic expression of genetic markers
of white cell infiltration, recruitment/activation, and
initiation/propagation of inflammatory signals. Liver
mRNA expression of macrophage marker F4/80 was only
increased in theWD-fed LCR rats (Fig. 2A,3-fold, inter-
action, P < 0.05). In addition, WD resulted in more
dramatic increases in monocyte chemoattractant protein
1 (MCP-1), IL-1β, and the toll-like receptors 2, 4, and 9
(TLR2, 4 and9) in LCRcompared toHCRrats (Fig. 2B and
C, significant interactions,P<0.05).Hepatic expressionof
death receptors TRAIL2, Fas andTNFR1were all increased
in LCRWD compared to LFD andHCRWD rats (Fig. 2D,
P<0.05). Furthermore, significantWD-induced increases
in liver inflammatory gene expression of NLRP3, TNFa,
CD11c, CD68 and CD64 were observed in both strains
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(Table 3), with no effects of strain observed. These data
show that intrinsic aerobic capacity significantly alters
susceptibility to WD-induced NASH outcomes.
Liver fatty acid oxidation and acyl-carnitine profiles
Wehave previously shown that decreased intrinsic aerobic
capacity is associated with reduced liver complete fatty
acid oxidation (FAO) and more pronounced NAFLD
outcomes (Rector et al. 2008; Thyfault et al. 2009; Morris
et al. 2012, 2014, 2016). To further assess the role of
intrinsic aerobic capacity and chronic WD on liver lipid
oxidation, we performed FAO experiments in liver homo-
genate and determined liver and plasma acyl-carnitine
profiles. Chronic WD resulted in a 45% reduction of
complete FAO in both strains (Fig. 3A, P < 0.05), with
the HCR WD rats maintaining a 33% greater complete
FAO to CO2 compared to LCR rats (P < 0.05). WD
resulted in a significant decrease in acid-solublemetabolite
(ASM) production in both strains (HCR, 6%; LCR, 18%;
P < 0.05), but a larger decrease in LCR than HCR rats
(interaction, P < 0.05). These changes were not due
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Figure 2. High intrinsic aerobic capacity attenuates high-fat/high-cholesterol diet-induced expression
of markers of liver macrophage infiltration and inflammation
Gene expression in liver was determined by RT-PCR. Relative mRNA expression of genes for macrophage markers
(A), recruitment and activation (B), inflammation initiation and propagation (C), and death receptors (D) were
normalized to cyclophilin B (PPIB) and presented as means ± SEM (n = 7–8). §P < 0.05 interaction; ∗P < 0.05
main effect HCR vs. LCR; †P < 0.05 main effect LFD vs. WD; ∗∗P < 0.05 HCR vs. LCR within diet.
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Figure 3. Selection for increased running capacity results in greater hepatic fatty acid oxidation (FAO)
and acyl-carnitine flux
C© 2017 The Authors. The Journal of Physiology C© 2017 The Physiological Society
4918 E. M. Morris and others J Physiol 595.14
Liver homogenates were incubated with [14C]palmitate. Complete FAO (A) was determined by trapping 14CO2,
and acid-soluble metabolite (ASM) production was determined from the reaction buffer and normalized to liver
sample wet weight. Parallel incubations of liver homogenate were performed in the presence of the CPT-1
inhibitor, etomoxir, to determine non-CPT-1-mediated (B) complete FAO and ASM production. Liver acyl-carnitine
concentrations were determined by LC-MS/MS, and ratios (C) of C2/C4 and C4/C16 were compared to assess
complete FAO and β-oxidation, respectively. (D) Western blot analysis of liver homogenate was performed to assess
protein expression of CPT-1a and HADHA. Values are means ± SEM (n = 8). §P < 0.05 interaction; ∗P < 0.05
main effect HCR vs. LCR; †P < 0.05 main effect LFD vs. WD; ∗∗P < 0.05 HCR vs. LCR within diet; ††P < 0.05 LFD
vs. WD within strain.
to changes in protein expression of CPT-1a, (Fig. 3D).
However, both complete FAOandASMproduction appear
to associatewith totalHADHA(trifunctional enzyme sub-
unit a,mitochondria) protein expression, whichwas lower
in the LCR rats on LFD and was reduced in both groups
by the WD (Fig. 3D, P < 0.05).
While up to 90% of liver FAO is localized to
the mitochondria, the impact of increased peroxisomal
β-oxidation on liver disease initiation and progression has
not been extensively studied. To approximate peroxisomal
FAO, liver homogenate FAO was determined in the pre-
sence of the CPT-1 inhibitor etomoxir. In the presences of
etomoxir, the relative differences for all FAO data (Fig. 3B)
strongly mirrored the absolute values above. Complete
FAO due to peroxisomal oxidation was 40% higher
in the HCR compared to LCR rats regardless of diet
(P < 0.05) and ASM production from peroxisomes was
also higher in HCR rats on LFD (P < 0.05). WD lowered
peroxisomal ASM production only in the HCR but not
the LCR rats (P < 0.05). These data suggest that intrinsic
aerobic capacity impacts liver peroxisomal FAO and may
impact susceptibility for liver disease.
Acyl-carnitine profiling was performed in liver and
plasma to further characterize the role of differing intrinsic
aerobic capacity upon lipid metabolism, (Fig. 3C and
Table 4).WDproduced a significant decrease in the C2/C4
acyl-carnitine ratio compared to LFD (P < 0.05) in both
strains due to increases in C4-carnitine. However, the
change in C2/C4 was significantly greater following WD
in the HCR than the LCR rats (interaction, P < 0.05). An
opposite effect was observed for the C4/C16 acyl-carnitine
ratio, where it was increased in both groups following
WD, but was increased to a greater extent in the LCR
rats (P < 0.05). A decrease in the C2/C4 and an
increase in the C4/C16 acyl-carnitine ratios suggest a
decrease in complete fatty acid oxidation and/or an
increase in β-oxidation leading to the subsequent
accumulation of short-chain C4-carnitine. Additionally,
liver long-chain (C14 and C16) acyl-carnitine levels
were lower in the LCR compared to HCR rats, and
were lowered in both strains following WD exposures
(P < 0.05). Further, medium-chain (C8) acyl-carnitines
were lowered by WD in both strains (P < 0.05). In
addition to implicating increased liverβ-oxidationof these
species following chronic WD, the lower liver levels of
medium- and long-chain acyl-carnitines also may suggest
greater diversion of excess liver acyl-CoAs toward the
TAG synthesis pathway. This interpretation is supported
by the gross steatosis observed in both strains on the
WD. Hepatic free carnitine decreased following WD in
both strains (Table 4, P < 0.05), but the reduction was
significantly greater in the LCR vs. HCR rats (inter-
action, P < 0.05). WD diet caused an equal increase
in plasma free carnitine in both strains suggesting that
hepatic tissue metabolism following WD was different
between strains. Plasma and liver C2-carnitine patterns
were similar in the HCR rats on both diets but the WD
significantly decreased liver C2-carnitine in the LCR rats.
All told, these data demonstrate that reduced intrinsic
aerobic capacity is associated with decreased hepatic FAO
and FAO adaptability to the WD challenge.
Liver mitochondrial content, respiration and energy
state
Reductions in hepatic mitochondrial number, mito-
chondrial respiratory capacity (MRC), and energy state
have also been implicated in the development of NAFLD
(Begriche et al. 2013; Arguello et al. 2015). Hepatic
mitochondrial content, assessed by citrate synthase
activity, was reduced 23% by WD in both strains
(Fig. 4A, P < 0.05); however, content remained 16%
higher in the HCR than LCR rats (P < 0.05). We pre-
viously reported (Morris et al. 2014, 2016) evidence of
reduced liver mitochondria TCA cycle flux (measured
by 2-[14C]pyruvate oxidation) combined with reduced
MRC in LCR rats. Here we report that WD lowered
2-[14C]pyruvate oxidation in isolated mitochondria to a
greater extent in the LCR vs. HCR rats (69% vs. 28%,
respectively; Fig. 4A, P < 0.05). Similarly, WD feeding
reduced ADP-stimulated mitochondrial respiration of
glutamate through complex I and complex I and II
to a greater extent in LCR vs. HCR rats (Fig. 4B,
P < 0.05), whereas, maximal uncoupled mitochondrial
respiration of glutamate was significantly increased
following WD feeding in HCR compared with LCR rats
(Fig. 4B,P<0.05).Mitochondrial respiration experiments
with pyruvate and palmitoyl-carnitine produced similar
findings (data not shown).
Because of differences in hepatic FAO and MRC, we
also measured hepatic energy status (NAD and adenine
nucleotide pools). LCR rats displayed greater NADH than
C© 2017 The Authors. The Journal of Physiology C© 2017 The Physiological Society
J Physiol 595.14 Aerobic capacity impacts diet-induced steatohepatitis 4919
Table 4. Plasma and liver acyl-carnitine profiles
HCR LCR
LFD WD LFD WD Interaction
Serum (μM)
Free carnitine 40.64 ± 2.85 49.87 ± 2.49†† 55.31 ± 2.64∗ 57.93 ± 2.38∗ NS
Acetyl-carnitine (C2) 27.77 ± 2.26 29.88 ± 1.58 39.63 ± 3.07∗ 36.53 ± 2.21∗ NS
Isopropyl-carnitine (C3) 0.1532 ± 0.0150 0.2467 ± 0.0122† 0.2207 ± 0.0143∗ 0.3662 ± 0.0132∗ ,† P < 0.07
Butyryl-carnitine (C4) 0.2962 ± 0.0245 0.3218 ± 0.0463 0.4153 ± 0.0195∗ 0.4610 ± 0.0492∗ NS
Isovaleryl-carnitine (C5) 0.0112 ± 0.0021 0.0107 ± 0.0003 0.0113 ± 0.0007 0.0127 ± 0.0006 NS
Octanoyl-carnitine (C8) 0.0139 ± 0.0007 0.0126 ± 0.0004 0.0134 ± 0.0004 0.0137 ± 0.0006 NS
Mistroyl-carnitine (C14) 0.0546 ± 0.0041 0.0491 ± 0.0038 0.0555 ± 0.0027 0.0424 ± 0.0017†† NS
Palmitoyl-carnitine (C16) 0.3358 ± 0.0488 0.3361 ± 0.0400 0.3652 ± 0.0267 0.3138 ± 0.0215 NS
Liver (nmol g−1)
Free carnitine 304.2 ± 10.9 209.3 ± 23.2† 335.9 ± 7.2∗ 123.6 ± 7.9∗ ,† P < 0.001
Acetyl-carnitine (C2) 105.7 ± 10.2 109.3 ± 9 99.4 ± 11.2 110.3 ± 8.2 NS
Isopropyl-carnitine (C3) 3.22 ± 0.74 3.91 ± 0.36 1.72 ± 0.18∗∗ 3.09 ± 0.36†† NS
Butyryl-carnitine (C4) 0.650 ± 0.230 3.119 ± 0.611† 1.315 ± 0.362 5.048 ± 1.370† NS
Isovaleryl-carnitine (C5) 0.1321 ± 0.0190 0.1566 ± 0.217 0.1434 ± 0.0123 0.1052 ± 0.181 NS
Octanoyl-carnitine (C8) 0.0592 ± 0.0106 0.0226 ± 0.0052† 0.0555 ± 0.0110 0.0151 ± 0.0014† NS
Mistroyl-carnitine (C14) 1.250 ± 0.232 0.216 ± 0.061† 0.676 ± 0.142∗∗ 0.213 ± 0.049† P < 0.07
Palmitoyl-carnitine (C16) 1.185 ± 0.187 0.490 ± 0.133† 0.671 ± 0.136∗ 0.266 ± 0.030∗ ,† NS
Liver carnitine ratios
C2/C3 48.4 ± 7.9 29.2 ± 3.2† 52.8 ± 4.6 37.5 ± 2.9† NS
C2/C4 285.2 ± 65.0 44.5 ± 9.6† 110.3 ± 33.1∗ 30.3 ± 5.0∗ ,† P < 0.05
C4/C16 0.312 ± 0.078 7.480 ± 2.022† 2.929 ± 1.230∗ 14.276 ± 2.894∗ ,† NS
C8/C16 0.039 ± 0.006 0.033 ± 0.004 0.091 ± 0.012∗ 0.066 ± 0.007∗ ,†† NS
Plasma and liver acyl-carnitines were quantitated by LC-MS/MS. Liver acyl-carnitines were normalized to liver samples weight. All
values are presented as means ± SEM (n = 7–8). P < 0.05 interaction; ∗P < 0.05 main effect HCR vs. LCR; †P < 0.05 main effect LFD vs.
WD; ∗∗P < 0.05 HCR vs. LCR within diet; ††P < 0.05 LFD vs. WD within strain. NS, not significant.
HCR rats on LFD (Table 5, P < 0.05). WD significantly
reduced NAD+, NADH, total NAD, AMP, ADP, ATP
and total nucleotides in both strains (P < 0.05). To
reduce the impact of WD-induced hepatomegaly on the
interpretation of these findings, we calculated within
liver sample NAD+/NADH ratio and adenine energy
state. Interestingly, no difference due to strain or diet
was observed in hepatic energy charge as calculated from
adenine nucleotides (Fig. 4C). WD significantly lowered
NAD+/NADH in both strains (P < 0.05). Importantly,
the greater NADH of the LCR rats (Table 5) resulted
in a lower liver NAD+/NADH ratio compared to HCR
rats on both diets (Fig. 4C, P < 0.05). Chronically
reduced NAD+/NADH within the LCR rats is suggestive
of greater oxidative stress (Fisher-Wellman & Neufer,
2012), which was further supported by higher hepatic
lipid peroxidation (4-HNE) and evidence of hydrogen
peroxide handling (GPx1) in the LCR over HCR rats
(Fig. 5, P < 0.05). In total, these data show that low
intrinsic aerobic capacity tracks with reduced liver
mitochondrial content, TCA cycle flux and respiratory
capacity that is worsened with a WD. In addition,
low-fitness LCR rats displayed a more reduced oxidative
state, particularly following chronic WD feeding.
Liver mitochondrial integrity and effector caspase
activation
Mitochondria serve as a primary cellular site for
regulation and integration of intra- and extracellular
signals modulating inflammatory and cell death
signalling (Guicciardi et al. 2013). We measured hepatic
mitochondrial specific content of Bcl-2 family proteins
involved in regulating mitochondrial outer membrane
permeability (MOMP) and downstream effector caspases
to assess the impact of divergent aerobic capacity andWD
on these portions of the cell death cascade. Mitochondrial
content of the anti-apoptotic protein Bcl-2 was increased,
while Bcl-xLwas decreased byWD in both strains (Fig. 6A,
P < 0.05). Pro-apoptotic Bcl-2 family members, Bax,
Bak and cleaved Bcl-xL, were all significantly increased
following WD in both strains (Fig. 6B, P < 0.05). Inter-
estingly, cleaved Bcl-xL mitochondrial localization was
greater in LCR rats on both LFD andWD (29% and 39%,
respectively) compared to HCR rats.
To assess whether these elevated markers of mito-
chondrial outer membrane permeability were associated
with activation of downstream pathways, caspase 3 and 7
protein activation status was determined (Fig. 6C). Both
C© 2017 The Authors. The Journal of Physiology C© 2017 The Physiological Society
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caspase 3 and 7 showed greater activation in the LCR
compared to HCR rats regardless of diet (60% and
4-fold, respectively, P < 0.05). WD increased activation
of caspase 3 but not 7 in HCR and LCR rats (39%
and 48%, respectively, P < 0.05). Thus, WD-induced
changes in hepatic mitochondrial integrity between rats
with divergent intrinsic aerobic capacities do not result in
similarly associated changes in caspase activation. Further,
selection for low aerobic capacity is associatedwith greater
basal activation of hepatic effector caspases, which is
exacerbated by chronic WD feeding.
Discussion
Despite numerous findings in humans that aerobic
capacity impacts liver disease progression, mechanisms
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Figure 4. Liver mitochondrial content, respiratory capacity and hepatic NAD+/NADH ratio is higher in
rats with high intrinsic aerobic capacity
A, markers of hepatic mitochondrial content and TCA cycle flux are presented as citrate synthase activity in
liver homogenate and 2-[14C]pyruvate oxidation to CO2. B, liver mitochondrial respiration was determined by
measurement of O2 consumption using a Clark electrode system in the presence of glutamate (+malate and
succinate) in different respiratory states (basal, state 3 and uncoupled). C, hepatic NAD+, NADH, ATP, ADP, and
AMP were determined by LC-MS/MS. The mitochondrial energy state is represented as the ratio of NAD+ to
NADH, and adenine energy charge. Values are means ± SEM (n = 7–8). §P < 0.05 interaction; ∗P < 0.05 main
effect HCR vs. LCR; †P < 0.05 main effect LFD vs. WD; ††P < 0.05 LFD vs. WD within strain.
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Table 5. Liver NAD and adenine nucleotides
HCR LCR
LFD WD LFD WD Interaction
NAD pool (nmol g−1)
NAD+ 1022.6 ± 40.3 641.0 ± 31.3† 1078.4 ± 84.6 553.0 ± 44.7† NS
NADH 158.8 ± 10.0 130.6 ± 8.1† 239.7 ± 28.6∗ 158.4 ± 9.2∗ ,† P = 0.06
Total NAD 1181.5 ± 38.1 783.9 ± 40.4† 1318.1 ± 101.7∗ 711.3 ± 42.9∗ ,† P = 0.06
Adenine nucleotide pool (nmol g−1)
AMP 855.2 ± 42.4 663.9 ± 72.4† 938.1 ± 64.9 581.8 ± 70.6† NS
ADP 1549.7 ± 90.2 1220.7 ± 101.9† 1863.9 ± 137.7 1186.2 ± 111.7† NS
ATP 2254.2 ± 76.2 1553.7 ± 82.3† 2467.0 ± 117.6 1739.8 ± 180.6† NS
Total adenine pool 4659.1 ± 124.8 3438.3 ± 217.5† 5429.2 ± 376.8 3507.8 ± 242.5† NS
Chronic high-fat/high-cholesterol diet lowers liver adenine nucleotides in HCR/LCR rats. Liver adenine nucleotide (NAD+, NADH, AMP,
ADP, and ATP) quantitation was determined by LC-MS/MS and all values were normalized to liver sample weight. All values are
presented as means ± SEM (n = 7–8). P < 0.05 interaction; ∗P < 0.05 main effect HCR vs. LCR; †P < 0.05 main effect LFD vs. WD;
∗∗P < 0.05 HCR vs. LCR within diet; ††P < 0.05 LFD vs. WD within strain.
remain unknown. Likewise, factors that drive trans-
ition from NAFLD to NASH in only a proportion
of patients remain unknown. Here, we find low
aerobic fitness and reduced initial hepatic mitochondrial
oxidative capacity enhance susceptibility to WD-induced
NASH, as characterized by increased serum ALT,
inflammatory cell infiltration, effector caspase activation,
and mRNA expression of pro-inflammatory and cell
death signalling genes. Importantly, evidence of trans-
ition to NASH was only found in the low-fitness LCR
rats despite both high-fitness HCR and low-fitness
LCR rats developing robust hepatomegaly and steatosis.
Overall, the data show that intrinsic aerobic capacity
and hepatic mitochondrial oxidative capacity impact
cholesterol ester accumulation and inflammatory status
following WD, and support the concept that these
physiological factors drive risk for transition fromNAFLD
to NASH.
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Figure 5. Protein expression of markers of
oxidative stress and anti-oxidant enzymes in
isolated liver mitochondria
Data are presented as means ± SEM (n = 7–8).
A, 4-hydroxy-2-nonenal (4-HNE); B, superoxide
dismutase 2 (SOD2); C, uncoupling protein 2
(UCP2); D, glutathione peroxidase 1 (GPx1).
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LFD vs. WD within strain.
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The roles of both maladaptive liver cholesterol
metabolismandhepaticmitochondrial functionhavebeen
widely investigated in the development of NAFLD (Min
et al. 2012; Arguello et al. 2015; Bashiri et al. 2016). Excess
dietary cholesterol results in hepatomegaly and steatosis,
reduced liver complete and total FAO, and decreased
ADP-coupled mitochondrial respiration in rats (Rogers
et al. 1980; Fungwe et al. 1993), while chemical inhibition
of endogenous cholesterol synthesis increased hepatic
mitochondrial andperoxisomal FAOwithprotection from
NASH development (Roglans et al. 2002; Park et al. 2016).
In the current study, WD reduced FAO (complete and
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Figure 6. Low intrinsic aerobic capacity increases susceptibility to liver mitochondrial localization of
pro-apoptotic proteins and associated effector caspase activation
A and B, mitochondrial localization of proteins involved in the regulation of mitochondrial outer membrane
permeability (MOMP) were determined in isolated liver mitochondria by Western blot analysis. A, anti-MOMP
opening (Bcl-2 and Bcl-xL). B, pro-MOMP opening (Bax, Bak and cleaved BCL-xL). C, liver expression of active
(cleaved) effector caspases, caspase-3 and caspase-7, was determined in liver homogenate by Western blot
analysis. D, representative blots. All values are presented as means ± SEM (n = 7–8). ∗P < 0.05 main effect HCR
vs. LCR, † P < 0.05 main effect LFD vs. WD, ∗∗ P < 0.05 HCR vs. LCR within diet.
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incomplete) and MRC in both strains, but the LCR rats
started at a lower level and remained lower than HCR
rats. In addition, the impact of the lower levels of FAO
and MRC in isolated mitochondria is further magnified
by the overall lower mitochondrial content in the LCR vs.
HCR rats. Similar findings were observed with markers
of liver mitochondrial content, TCA cycle flux and free
hepatic carnitine content. We have previously observed
that LCR rats have increased susceptibility to steatosis,
which was associated with reduced whole body FAO,
metabolic inflexibility, decreased liver FAO and reduced
MRC (Thyfault et al. 2009;Morris et al. 2014, 2016). These
data are similar to humanNAFLD subjects who have been
shown to have physiological features that include lower
aerobic capacity, metabolic inflexibility, decreased whole
body FAO, and reducedβ-hydroxybutyrate, all factors that
suggest reduced liver FAO capacity (Croci et al. 2012).
Additional rodent studies have demonstrated that reduced
hepatic complete FAO is associated with development and
progression of hepatic steatosis (Rector et al. 2008, 2010)
while molecular therapies to enhance FAO effectively
treat or prevent steatosis. Importantly, our findings of
greater WD-induced reductions in mitochondrial FAO
and MRC in LCR rats appear to be independent of TAG
accumulation, suggesting that hepatic TAG stores are
not the primary driver of inflammation and oxidative
stress, but rather that hepatic mitochondrial function
plays a more important role. These results are similar
to the athletes’ paradox by which both athletes and
insulin-resistant obese individuals display dramatically
different insulin sensitivity and inflammation despite both
displaying elevated intramuscular lipids (Goodpaster et al.
2001). Much like in muscle, it is the possible that the
overall balanceof hepaticmitochondrial content/oxidative
capacity and lipid stores interact to impact outcomes
related to inflammation and insulin resistance.
Mitochondria are hypothesized to serve as a cellular
point of integration of intra- and extracellular signals
ultimately producing inflammation and cell death
signalling (Guicciardi et al. 2013; Luedde et al. 2014;
Arguello et al. 2015). Dysregulated liver cholesterol
homeostasis and accumulation has been implicated
in the initiation of hepatic mitochondrial dysfunction
(Montero et al. 2010), which is associated with NAFLD
severity (Min et al. 2012). Mitochondrial membranes
are inherently cholesterol poor (Montero et al. 2010),
with increased mitochondrial membrane cholesterol
producing decreased ATP synthesis (Campbell & Chan,
2007) and decreased mitochondrial antioxidant capacity
(Fernandez-Checa & Kaplowitz, 2005). In the present
study, maximal ADP-coupled MRC was lowered to a
greater extent following WD in the LCR rats, results
that tracked with greater induction of mitochondrial
oxidative stress. Previously, increased free cholesterol levels
were highly associated with NASH-related mitochondrial
dysfunction (Min et al. 2012; Gan et al. 2014). Inter-
estingly, here the reductions in MRC and increased
markers of oxidative stress occurred in parallel with an
observed increase in cholesterol ester in LCR compared
to HCR rats on the WD. Chronic accumulation of
mitochondrial cholesterol is associated with increased
mitochondrial localization of pro-apoptotic Bcl-2 family
members and activation of MOMP (Montero et al. 2010).
Chronic WD feeding in this study resulted in similar
increases in mitochondrial protein localization of Bax and
Bak in both strains, while lowering the predominant liver
anti-MOMP Bcl family member, Bcl-xL. Mitochondrial
localization of the pro-apoptotic Bcl-xL cleavage product
(Clem et al. 1998; Fujita et al. 1998)was significantly higher
in the WD-fed LCR rats compared to HCR rats, and was
strongly associated with the observed increases inmarkers
of advance NAFLD.
We found that effector caspase activation was higher
in LCR compared to HCR rats regardless of diet, with
WD dramatically increasing caspase-3 activation further.
This increase in caspase-3 activation could potentially
explain the observed increase in cleaved Bcl-xL (Clem
et al. 1998; Fujita et al. 1998). The increased effector
caspase activation also suggests greater intrinsic/extrinsic
cell death signalling in the LCR on WD, which is further
supported by the observed increases in cell death receptor
expression. As mentioned, there is considerable evidence
that loss of mitochondrial function and excess cholesterol
can result in propagation of these intrinsic/extrinsic cell
death signals (Guicciardi et al. 2013; Luedde et al. 2014;
Arguello et al. 2015). However, any increased cell death
signalling in the LCR rats on WD is early in the disease
process as assessmentof cell deathbyTUNELassay showed
no differences between HCR and LCR rats (data not
shown). Together, these data suggest that intrinsically
low aerobic capacity results in increased susceptibility to
WD-induced steatohepatitis due to lower mitochondrial
respiratory capacity, increased oxidative stress and greater
activation of effector caspases.
In summary, we demonstrate that intrinsic aerobic
capacity impacts susceptibility for WD-induced NASH.
Lower initial levels and further declines in liver FAO
and MRC paired with excessive liver cholesterol ester
accumulation lead to greater increases in several markers
of liver damage and inflammation in the low-fitness
LCR compared to the high-fitness HCR rats. Of note,
while high intrinsic aerobic capacity HCR rats were less
susceptible to many of the liver mal-adaptations induced
by a WD, HCR rats were not completely protected
against hepatomegaly/liver TAG accumulation or against
a loss of mitochondrial FAO or MRC unlike our pre-
vious findings with acute and chronic high-fat diets
(Thyfault et al. 2009; Morris et al. 2014, 2016). These
data support a novel concept that aerobic capacity and
hepatic mitochondrial phenotype may play a critical role
C© 2017 The Authors. The Journal of Physiology C© 2017 The Physiological Society
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in whetherNAFLD transitions toNASH, links that require
further examination inhumanpatients.Overall, these data
provide new insight into how intrinsic aerobic capacity
may influence the onset and progression of metabolic
disease through hepatic mitochondrial oxidative capacity.
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